Oral fingolimod or intramuscular interferon for relapsing multiple sclerosis JA Cohen, F Barkhof, G Comi, HP Hartung, BO Khatri, X Montalban, ... New England Journal of Medicine 362 (5), 402-415, 2010 | 2803 | 2010 |
A placebo-controlled trial of oral cladribine for relapsing multiple sclerosis G Giovannoni, G Comi, S Cook, K Rammohan, P Rieckmann, ... New England Journal of Medicine 362 (5), 416-426, 2010 | 1135 | 2010 |
Effect of glatiramer acetate on conversion to clinically definite multiple sclerosis in patients with clinically isolated syndrome (PreCISe study): a randomised, double-blind … G Comi, V Martinelli, M Rodegher, L Moiola, O Bajenaru, A Carra, ... The Lancet 374 (9700), 1503-1511, 2009 | 784 | 2009 |
Randomized placebo-controlled trial of mitoxantrone in relapsing-remitting multiple sclerosis: 24-month clinical and MRI outcome E Millefiorini, C Gasperini, C Pozzilli, F D’andrea, S Bastianello, ... Journal of neurology 244, 153-159, 1997 | 379 | 1997 |
Comparison of fingolimod with interferon beta-1a in relapsing-remitting multiple sclerosis: a randomised extension of the TRANSFORMS study B Khatri, F Barkhof, G Comi, HP Hartung, L Kappos, X Montalban, ... The Lancet Neurology, 2011 | 298 | 2011 |
Cognitive impairment and its relation with disease measures in mildly disabled patients with relapsing–remitting multiple sclerosis: baseline results from the Cognitive … F Patti, MP Amato, M Trojano, S Bastianello, MR Tola, B Goretti, L Caniatti, ... Multiple Sclerosis Journal 15 (7), 779-788, 2009 | 263 | 2009 |
Grey matter loss in relapsing–remitting multiple sclerosis: a voxel-based morphometry study A Prinster, M Quarantelli, G Orefice, R Lanzillo, A Brunetti, C Mollica, ... Neuroimage 29 (3), 859-867, 2006 | 227 | 2006 |
Cognitive impairment at diagnosis predicts 10-year multiple sclerosis progression M Moccia, R Lanzillo, R Palladino, KCM Chang, T Costabile, C Russo, ... Multiple Sclerosis Journal 22 (5), 659-667, 2016 | 157 | 2016 |
Pregnancy decision-making in women with multiple sclerosis treated with natalizumab: I: Fetal risks E Portaccio, P Annovazzi, A Ghezzi, M Zaffaroni, L Moiola, V Martinelli, ... Neurology 90 (10), e823-e831, 2018 | 153 | 2018 |
A genome-wide association meta-analysis identifies a novel locus at 17q11. 2 associated with sporadic amyotrophic lateral sclerosis I Fogh, A Ratti, C Gellera, K Lin, C Tiloca, V Moskvina, L Corrado, ... Human molecular genetics 23 (8), 2220-2231, 2014 | 138 | 2014 |
Effects of immunomodulatory treatment with subcutaneous interferon beta-1a oncognitive decline in mildly disabled patients with relapsing—remitting multiple sclerosis F Patti, MP Amato, S Bastianello, L Caniatti, E Di Monte, P Ferrazza, ... Multiple Sclerosis Journal 16 (1), 68-77, 2010 | 124 | 2010 |
Genetic mapping to 10q23. 3-q24. 2, in a large Italian pedigree, of a new syndrome showing bilateral cataracts, gastroesophageal reflux, and spastic paraparesis with amyotrophy M Seri, R Cusano, P Forabosco, R Cinti, F Caroli, P Picco, R Bini, ... The American Journal of Human Genetics 64 (2), 586-593, 1999 | 124 | 1999 |
Optical coherence tomography angiography retinal vascular network assessment in multiple sclerosis R Lanzillo, G Cennamo, C Criscuolo, A Carotenuto, N Velotti, F Sparnelli, ... Multiple Sclerosis Journal 24 (13), 1706-1714, 2018 | 111 | 2018 |
Epileptic seizures in multiple sclerosis: clinical and EEG correlations P Striano, G Orefice, V Brescia Morra, P Boccella, C Sarappa, R Lanzillo, ... Neurological Sciences 24, 322-328, 2003 | 107 | 2003 |
Dimethyl fumarate mediates Nrf2-dependent mitochondrial biogenesis in mice and humans G Hayashi, M Jasoliya, S Sahdeo, F Saccà, C Pane, A Filla, A Marsili, ... Human molecular genetics 26 (15), 2864-2873, 2017 | 105 | 2017 |
Brain tissue volume changes in relapsing-remitting multiple sclerosis: correlation with lesion load M Quarantelli, A Ciarmiello, VB Morra, G Orefice, M Larobina, R Lanzillo, ... Neuroimage 18 (2), 360-366, 2003 | 101 | 2003 |
Safety and efficacy of natalizumab in children with multiple sclerosis A Ghezzi, C Pozzilli, LME Grimaldi, V Brescia Morra, F Bortolon, R Capra, ... Neurology 75 (10), 912-917, 2010 | 98 | 2010 |
Natalizumab in the pediatric MS population: results of the Italian registry A Ghezzi, L Moiola, C Pozzilli, V Brescia-Morra, P Gallo, LME Grimaldi, ... BMC neurology 15, 1-6, 2015 | 92 | 2015 |
A clinical comparison of trigeminal neuralgic pain in patients with and without underlying multiple sclerosis R De Simone, E Marano, V Brescia Morra, A Ranieri, P Ripa, M Esposito, ... Neurological Sciences 26, s150-s151, 2005 | 90 | 2005 |
Atorvastatin combined to interferon to verify the efficacy (ACTIVE) in relapsing—remitting active multiple sclerosis patients: a longitudinal controlled trial of combination … R Lanzillo, G Orefice, M Quarantelli, C Rinaldi, A Prinster, G Ventrella, ... Multiple Sclerosis Journal 16 (4), 450-454, 2010 | 89 | 2010 |